Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Corvus Pharmaceuticals Inc buy Oppenheimer Holdings Inc.

Corvus Pharmaceuticals Inc
Start price
€1.67
20.03.24 / 50%
Target price
€6.45
20.03.25
Performance (%)
-16.05%
Price
€1.32
26.04.24
Summary
This prediction is currently active. The prediction for Corvus Pharmaceuticals Inc disappoints with a performance of -16.05%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Corvus Pharmaceuticals Inc 4.747% 4.747%
iShares Core DAX® 2.594% -1.861%
iShares Nasdaq 100 3.553% -2.064%
iShares Nikkei 225® 0.687% -8.704%
iShares S&P 500 2.209% -1.988%

Comments by Oppenheimer_Holdings for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -16.05%
Target price 6.453
Change
Ends at 20.03.25

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat

Oppenheimer Holdings Inc. 
0
Report Share
20.03.24

Stopped prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.81
17.08.23
-
17.08.24
-26.85%
26.04.24

Oppenheimer Holdings Inc. 
17.08.23 50%